The purpose of this study is to investigate pancreatic adenocarcinoma and its association with cancer cachexia.
This study evaluates the relationship between specific genomic polymorphisms and cancer cachexia in patients with pancreatic adenocarcinoma. It focuses on identifying biomarkers that might be linked to this condition.
- Who can participate: Participants must be 18 years or older and have confirmed pancreatic adenocarcinoma, either locally advanced unresectable or metastatic. They must be able to provide a blood or buccal sample for the study.
- Study details: Participants will provide blood or buccal samples during regular clinic visits. These samples will be analyzed to study genomic polymorphisms.